Dr. Justin Omeed Oveyssi, DO

Dr. Oveyssi practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Oveyssi's NPI, 1093248999, was assigned on April 6, 2017. Dr. Oveyssi graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 2017. Dr. Oveyssi holds California license 16908.

Dr. Oveyssi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Oveyssi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Oveyssi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Oveyssi to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oveyssi practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Oveyssi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Oveyssi is licensed in California.

CMS data shows 824 Medicare services from Dr. Oveyssi across 9 procedure codes in 2024, for 254 Medicare patients. Medicare paid $64,285 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 254 Medicare patients who saw Dr. Oveyssi in 2024. The largest group is under 65, with 126 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 5.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oveyssi's median patient age at 57, with 42% women.

In 2024, Dr. Oveyssi wrote 1,345 Medicare Part D claims for 249 patients. 89% of them were for generic drugs. CMS names the drug for 1,168 of them, across 21 drugs with 11 or more claims each, at $103,335 in total drug cost. In 2023, CMS named 607 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Oveyssi for performance year 2024, reported as part of a group. Dr. Oveyssi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oveyssi as offering telehealth.

Dmand AI links 3 papers to Dr. Oveyssi, published from 2020 to 2022. Dr. Oveyssi's most frequent co-authors are Kamyar Zadeh Kalantar-Zadeh, MD, Csaba Pal Kovesdy, MD and Connie Meeyoung Rhee, MD.

Dr. Oveyssi graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 2017.